Citi Pharma Ltd News
MettisPositive coverageCiti Pharma acquires 20% stake in Pakheim InternationalCiti Pharma acquired a 20 per cent stake in Pakheim International Pharma.
BRNeutral coverageCCP allows Citi Pharma to acquire PakheimThe CCP approved Citi Pharma’s proposed acquisition of all Pakheim shares without competition concerns.
ProfitPositive coverageCiti Pharma secures CCP approval to acquire 100% stake in Pakheim International PharmaThe CCP approved Citi Pharma's purchase of 100% of Pakheim by order dated October 9, 2026.- MettisPositive coverageCiti Pharma gets CCP Nod for 100% acquisition of Pakheim International PharmaThe CCP authorised Citi Pharma's proposed acquisition of 100% of Pakheim International Pharma.
BRPositive coverageCiti Pharma receives CCP nod to acquire Pakheim InternationalThe Competition Commission approved Citi Pharma's proposed acquisition of 100% of Pakheim International Pharma.- MettisNegative coverageCPHL FY26 profit softens 11%Net profit fell 11% to Rs790.33m for the year ended June 30, 2026.
- MettisNeutral coverageCiti Pharma gets shareholder nod to alter memorandum for cannabis businessShareholders approved changing the Memorandum of Association to permit cannabis and hemp activities.
BRPositive coverageCiti Pharma Limited: performance and outlookNet sales rose 6.81 percent to Rs10,787.56 million in 9MFY26.
ProfitNeutral coverageCiti Pharma shareholders approve property demerger into Citi Core HoldingsShareholders approved the property demerger at an extraordinary meeting held on July 8, 2026.- MettisNeutral coverageCiti Pharma approves REIT demerger planCiti Pharma's board approved a demerger scheme on 8 July 2026.
More market stories are on the PSX news page.
Community
CPHL discussion
3 company updates about Citi Pharma Ltd
Not enough bullish or bearish views in the last 7 days yet.
No member comments yet. Be the first to share your view on Citi Pharma Ltd.
Comments are the personal opinions of community members, not investment advice. Do your own research before you invest. Company updates from @InvestifyUpdates are automatic summaries of PSX announcements, so check the original announcement.
Join the discussionAbout CPHL news
Citi Pharma Ltd (CPHL) is listed on the Pakistan Stock Exchange in the Pharmaceuticals sector. Read the latest Investify News Desk reports and publisher stories linked to this company, each tagged with how the story reads for the stock. A headline is context, not a signal: check it against the company's own announcements.
CPHL news questions
Where can I read the latest news about Citi Pharma Ltd (CPHL)?
This page lists the most recent stories linked to Citi Pharma Ltd: reports by the Investify News Desk and summaries of stories from Pakistani publishers. Each links to its own page with the sources it is based on.
What does the sentiment label on a CPHL story mean?
It describes how the story reads for CPHL (positive, negative or neutral), assigned automatically from the text. It is not a rating, a forecast of the share price or a recommendation to trade.
Where do I confirm a CPHL headline?
Company news is confirmed by the company's own filings. Open the announcements for CPHL to read the notice itself, with its dates and terms.
CPHL company announcementsExplore other Pharmaceuticals shares
PSX guides
Read the news with the filings
How to check a headline against the company's own announcements and results before you act on it.
How to Research PSX Companies Before Buying Shares
A practical PSX company research checklist for beginners: read stock pages, fundamentals, charts, technicals, announcements, annual reports and market news before buying.
Read guide
PSX Company Announcements Explained: Results, Dividends, Board Meetings, Book Closure, Rights and Bonus Issues
Learn what PSX company announcements mean - results, dividends, book closure, bonus shares and rights issues - and how to read them in Investify.
Read guide
Common Mistakes Beginners Make in the Pakistan Stock Exchange
A practical guide to common PSX beginner mistakes, including chasing tips, overtrading, ignoring risk, skipping research and not tracking portfolio decisions.
Read guideData source: Market data is provided under a Pakistan Stock Exchange data license held by Recube Technologies (investify.pk), listed on the official PSX services page. Quotes, charts and derived figures are for information only and may be delayed, adjusted or revised by the exchange.
Not financial advice: Investify is not a brokerage and does not provide investment, trading or financial advice. Nothing on this page is a recommendation to buy or sell any security. Do your own research or consult a licensed advisor before making investment decisions. Read our data & editorial policy.
